{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:35:57Z","timestamp":1747204557571,"version":"3.40.5"},"posted":{"date-parts":[[2023,1,20]]},"group-title":"In Review","reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,1,16]]},"abstract":"<title>Abstract<\/title><p>Emerging evidence implicates impaired microglia function and dysregulation of lipid metabolism in Alzheimer\u2019s disease (AD). Oleoylethanolamide (OEA), an endogenous lipid and PPAR\u03b1 agonist, has been shown to promote longevity in<italic>C. elegans<\/italic>through regulation of lysosome-to-nucleus signaling and cellular metabolism. Using a stable OEA analog, KDS-5104, we found that OEA-PPAR\u03b1 signaling promotes TFEB lysosomal activity independent of mTORC1 and upregulates cell-surface receptor CD36, leading to enhanced microglial A\u03b2 uptake and clearance. These are associated with the suppression of LPS-induced lipid droplet accumulation and inflammasome activation. Chronic treatment of the 5xFAD mice with KDS-5104 restored dysregulated profiles, reduced reactive gliosis and A\u03b2 pathology and rescued cognitive impairments. Together, our study provides support that augmenting OEA-mediated lipid signaling may offer therapeutic benefit against aging and AD through modulating lipid metabolism and microglia phagocytosis and clearance.<\/p>","DOI":"10.21203\/rs.3.rs-2484513\/v1","type":"posted-content","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T22:44:15Z","timestamp":1674254655000},"source":"Crossref","is-referenced-by-count":0,"title":["Oleoylethanolamide facilitates PPARa and TFEB signaling and attenuates Ab pathology in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.21203","author":[{"given":"Michele","family":"Comerota","sequence":"first","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasee","family":"Gedam","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xiong","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisheng","family":"Deng","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-6007","authenticated-orcid":false,"given":"Meng","family":"Wang","sequence":"additional","affiliation":[{"name":"Janelia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-7919","authenticated-orcid":false,"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5427-3798","authenticated-orcid":false,"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s Disease","volume":"362","author":"Querfurth HW","year":"2010","unstructured":"Querfurth, H. W. & LaFerla, F. M. Alzheimer\u2019s Disease. New England Journal of Medicine 362, 329\u2013344 (2010).","journal-title":"New England Journal of Medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1016\/j.neuron.2022.10.015","article-title":"Microglial efferocytosis: Diving into the Alzheimer\u2019s disease gene pool","volume":"110","author":"Romero-Molina C","year":"2022","unstructured":"Romero-Molina, C., Garretti, F., Andrews, S. J., Marcora, E. & Goate, A. M. Microglial efferocytosis: Diving into the Alzheimer\u2019s disease gene pool. Neuron 110, 3513\u20133533 (2022).","journal-title":"Neuron"},{"key":"ref3","first-page":"83","article-title":"Lysosomal signaling molecules regulate longevity in Caenorhabditis elegans","volume":"347","author":"Folick A","year":"2015","unstructured":"Folick, A. et al. Lysosomal signaling molecules regulate longevity in Caenorhabditis elegans. Science (1979) 347, 83\u201386 (2015).","journal-title":"Science (1979)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13195-021-00893-6","article-title":"Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease","volume":"13","author":"Borkowski K","year":"2021","unstructured":"Borkowski, K. et al. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease. Alzheimers Res Ther 13, 149 (2021).","journal-title":"Alzheimers Res Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-\u03b1","volume":"425","author":"Fu J","year":"2003","unstructured":"Fu, J. et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-\u03b1. Nature 425, 90\u201393 (2003).","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-\u03b1 agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu J","year":"2005","unstructured":"Fu, J., Oveisi, F., Gaetani, S., Lin, E. & Piomelli, D. Oleoylethanolamide, an endogenous PPAR-\u03b1 agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48, 1147\u20131153 (2005).","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nature13939","article-title":"Cell metabolism: Autophagy transcribed","volume":"516","author":"Settembre C","year":"2014","unstructured":"Settembre, C. & Ballabio, A. Cell metabolism: Autophagy transcribed. Nature 516, 40\u201341 (2014).","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12035-014-8743-4","article-title":"Pan-PPAR modulation effectively protects APP\/PS1 mice from amyloid deposition and cognitive deficits","volume":"51","author":"Kummer MP","year":"2015","unstructured":"Kummer, M. P. et al. Pan-PPAR modulation effectively protects APP\/PS1 mice from amyloid deposition and cognitive deficits. Mol Neurobiol 51, 661\u2013671 (2015).","journal-title":"Mol Neurobiol"},{"year":"2015","author":"Corbett GT","key":"ref9","unstructured":"Corbett, G. T., Gonzalez, F. J. & Pahan, K. Activation of peroxisome proliferator-activated receptor \u03b1 stimulates ADAM10-mediated proteolysis of APP. Proceedings of the National Academy of Sciences 112, 8445\u20138450 (2015)."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nbd.2018.12.007","article-title":"Cinnamic acid activates PPAR\u03b1 to stimulate lysosomal biogenesis and lower amyloid plaque pathology in an Alzheimer\u2019s disease mouse model","volume":"124","author":"Chandra S","year":"2019","unstructured":"Chandra, S., Roy, A., Jana, M. & Pahan, K. Cinnamic acid activates PPAR\u03b1 to stimulate lysosomal biogenesis and lower amyloid plaque pathology in an Alzheimer\u2019s disease mouse model. Neurobiol Dis 124, 379\u2013395 (2019).","journal-title":"Neurobiol Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15548627.2019.1596488","article-title":"Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model","volume":"16","author":"Luo R","year":"2020","unstructured":"Luo, R. et al. Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy 16, 52\u201369 (2020).","journal-title":"Autophagy"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abg4747","article-title":"Activation of PPAR\u03b1 enhances astroglial uptake and degradation of \u03b2-amyloid","volume":"14","author":"Raha S","year":"2021","unstructured":"Raha, S., Ghosh, A., Dutta, D., Patel, D. R. & Pahan, K. Activation of PPAR\u03b1 enhances astroglial uptake and degradation of \u03b2-amyloid. Sci Signal 14, (2021).","journal-title":"Sci Signal"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s13311-022-01275-y","article-title":"Synthetic PPAR agonist DTMB alleviates Alzheimer\u2019s Disease pathology by inhibition of chronic microglial inflammation in 5xFAD mice","volume":"19","author":"Oh E","year":"2022","unstructured":"Oh, E. et al. Synthetic PPAR agonist DTMB alleviates Alzheimer\u2019s Disease pathology by inhibition of chronic microglial inflammation in 5xFAD mice. Neurotherapeutics 19, 1546\u20131565 (2022).","journal-title":"Neurotherapeutics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/ADR-190104","article-title":"Gemfibrozil, a lipid-lowering drug, lowers amyloid plaque pathology and enhances memory in a mouse model of Alzheimer\u2019s disease via peroxisome proliferator-activated receptor \u03b1","volume":"3","author":"Chandra S","year":"2019","unstructured":"Chandra, S. & Pahan, K. Gemfibrozil, a lipid-lowering drug, lowers amyloid plaque pathology and enhances memory in a mouse model of Alzheimer\u2019s disease via peroxisome proliferator-activated receptor \u03b1. J Alzheimers Dis Rep 3, 149\u2013168 (2019).","journal-title":"J Alzheimers Dis Rep"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism","volume":"14","author":"Settembre C","year":"2013","unstructured":"Settembre, C., Fraldi, A., Medina, D. L. & Ballabio, A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 14, 283\u2013296 (2013).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1523\/JNEUROSCI.3788-13.2014","article-title":"Enhancing astrocytic lysosome biogenesis facilitates Abeta clearance and attenuates amyloid plaque pathogenesis","volume":"34","author":"Xiao Q","year":"2014","unstructured":"Xiao, Q. et al. Enhancing astrocytic lysosome biogenesis facilitates Abeta clearance and attenuates amyloid plaque pathogenesis. Journal of Neuroscience 34, 9607\u20139620 (2014).","journal-title":"Journal of Neuroscience"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.15252\/emmm.201303671","article-title":"Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB","volume":"6","author":"Polito VA","year":"2014","unstructured":"Polito, V. A. et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med 6, 1142\u20131160 (2014).","journal-title":"EMBO Mol Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","article-title":"Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing Abeta generation and amyloid plaque pathogenesis","volume":"35","author":"Xiao Q","year":"2015","unstructured":"Xiao, Q. et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing Abeta generation and amyloid plaque pathogenesis. Journal of Neuroscience 35, 12137\u201312151 (2015).","journal-title":"Journal of Neuroscience"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1084\/jem.20172158","article-title":"TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading","volume":"215","author":"Martini-Stoica H","year":"2018","unstructured":"Martini-Stoica, H. et al. TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. Journal of Experimental Medicine 215, 2355\u20132377 (2018).","journal-title":"Journal of Experimental Medicine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1038\/s41380-020-0738-0","article-title":"TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading","volume":"26","author":"Xu Y","year":"2021","unstructured":"Xu, Y. et al. TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading. Mol Psychiatry 26, 5925\u20135939 (2021).","journal-title":"Mol Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/jpet.106.105221","article-title":"Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties","volume":"318","author":"Astarita G","year":"2006","unstructured":"Astarita, G. et al. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties. Journal of Pharmacology and Experimental Therapeutics 318, 563\u2013570 (2006).","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley H","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. Journal of Neuroscience 26, 10129\u201310140 (2006).","journal-title":"Journal of Neuroscience"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1083\/jcb.201501002","article-title":"MiT\/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5","volume":"210","author":"Nezich CL","year":"2015","unstructured":"Nezich, C. L., Wang, C., Fogel, A. I. & Youle, R. J. MiT\/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. Journal of Cell Biology 210, 435\u2013450 (2015).","journal-title":"Journal of Cell Biology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee SS","year":"1995","unstructured":"Lee, S. S. et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15, 3012\u20133022 (1995).","journal-title":"Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1038\/s41467-018-05862-6","article-title":"mTOR-dependent phosphorylation controls TFEB nuclear export","volume":"9","author":"Napolitano G","year":"2018","unstructured":"Napolitano, G. et al. mTOR-dependent phosphorylation controls TFEB nuclear export. Nat Commun 9, 3312 (2018).","journal-title":"Nat Commun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"Settembre C","year":"2013","unstructured":"Settembre, C. et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol 15, 647\u2013658 (2013).","journal-title":"Nat Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR Signaling in growth control and disease","volume":"149","author":"Laplante M","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR Signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri M","year":"2017","unstructured":"Palmieri, M. et al. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun 8, 14338 (2017).","journal-title":"Nat Commun"},{"key":"ref29","first-page":"1429","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre C","year":"2011","unstructured":"Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science (1979) 332, 1429\u20131433 (2011).","journal-title":"Science (1979)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1074\/jbc.M114.610659","article-title":"Activation of peroxisome proliferator-activated receptor \u03b1 induces lysosomal biogenesis in brain cells","volume":"290","author":"Ghosh A","year":"2015","unstructured":"Ghosh, A. et al. Activation of peroxisome proliferator-activated receptor \u03b1 induces lysosomal biogenesis in brain cells. Journal of Biological Chemistry 290, 10309\u201310324 (2015).","journal-title":"Journal of Biological Chemistry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2009.09.003","article-title":"CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice","volume":"61","author":"Guijarro A","year":"2010","unstructured":"Guijarro, A., Fu, J., Astarita, G. & Piomelli, D. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice. Pharmacol Res 61, 27\u201333 (2010).","journal-title":"Pharmacol Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1523\/JNEUROSCI.1569-12.2012","article-title":"PPAR\u03b3\/RXR\u03b1-induced and CD36-mediated microglial amyloid-\u03b2 phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice","volume":"32","author":"Yamanaka M","year":"2012","unstructured":"Yamanaka, M. et al. PPAR\u03b3\/RXR\u03b1-induced and CD36-mediated microglial amyloid-\u03b2 phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice. J Neurosci 32, 17321\u201331 (2012).","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.1074\/jbc.M400346200","article-title":"Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-\u03b1 activator fenofibrate","volume":"279","author":"Gervois P","year":"2004","unstructured":"Gervois, P. et al. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-\u03b1 activator fenofibrate. Journal of Biological Chemistry 279, 16154\u201316160 (2004).","journal-title":"Journal of Biological Chemistry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne N","year":"2018","unstructured":"Bougarne, N. et al. Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation. Endocr Rev 39, 760\u2013802 (2018).","journal-title":"Endocr Rev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14509","DOI":"10.1038\/s41598-020-71510-z","article-title":"Untargeted lipidomics reveals progression of early Alzheimer\u2019s disease in APP\/PS1 transgenic mice","volume":"10","author":"Zhang X","year":"2020","unstructured":"Zhang, X., Liu, W., Zan, J., Wu, C. & Tan, W. Untargeted lipidomics reveals progression of early Alzheimer\u2019s disease in APP\/PS1 transgenic mice. Sci Rep 10, 14509 (2020).","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1039\/D1SC03486C","article-title":"Monitoring phagocytic uptake of amyloid \u03b2 into glial cell lysosomes in real time","volume":"12","author":"Prakash P","year":"2021","unstructured":"Prakash, P. et al. Monitoring phagocytic uptake of amyloid \u03b2 into glial cell lysosomes in real time. Chem Sci 12, 10901\u201310918 (2021).","journal-title":"Chem Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger J","year":"2020","unstructured":"Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 23, 194\u2013208 (2020).","journal-title":"Nat Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton HA","year":"2006","unstructured":"Overton, H. A. et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3, 167\u2013175 (2006).","journal-title":"Cell Metab"},{"key":"ref39","first-page":"800","article-title":"A gut lipid messenger links excess dietary fat to dopamine deficiency","volume":"341","author":"Tellez LA","year":"2013","unstructured":"Tellez, L. A. et al. A gut lipid messenger links excess dietary fat to dopamine deficiency. Science (1979) 341, 800\u2013802 (2013).","journal-title":"Science (1979)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","article-title":"The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"45","author":"W\u00f3jtowicz S","year":"2020","unstructured":"W\u00f3jtowicz, S., Strosznajder, A. K., Je\u017cyna, M. & Strosznajder, J. B. The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer\u2019s disease and other neurodegenerative disorders. Neurochem Res 45, 972\u2013988 (2020).","journal-title":"Neurochem Res"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1989","article-title":"Protocol for primary microglial culture preparation","volume":"6","author":"Lian H","year":"2016","unstructured":"Lian, H., Roy, E. & Zheng, H. Protocol for primary microglial culture preparation. Bio Protoc 6, (2016).","journal-title":"Bio Protoc"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s disease","volume":"100","author":"Litvinchuk A","year":"2018","unstructured":"Litvinchuk, A. et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s disease. Neuron 100, 1337\u20131353.e5 (2018).","journal-title":"Neuron"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.121109","article-title":"Concurrent cell type-specific isolation and profiling of mouse brains in inflammation and Alzheimer\u2019s disease","volume":"3","author":"Swartzlander DB","year":"2018","unstructured":"Swartzlander, D. B. et al. Concurrent cell type-specific isolation and profiling of mouse brains in inflammation and Alzheimer\u2019s disease. JCI Insight 3, 1\u201314 (2018).","journal-title":"JCI Insight"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1206","article-title":"An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Ghosh A","year":"2020","unstructured":"Ghosh, A. et al. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci Transl Med 12, (2020).","journal-title":"Sci Transl Med"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1988","article-title":"Microglial phagocytosis assay","volume":"6","author":"Lian H","year":"2016","unstructured":"Lian, H., Roy, E. & Zheng, H. Microglial phagocytosis assay. Bio Protoc 6, (2016).","journal-title":"Bio Protoc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual G","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41\u201345 (2017).","journal-title":"Nature"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2484513\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2484513\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:19:21Z","timestamp":1701749961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2484513\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":46,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2484513\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,1,20]]},"subtype":"preprint"}}